Infliximab effective after surgery

Research published in Clinical Gastroenterology and Hepatology shows the continuation of infliximab after surgery is effective and useful, even at a low dose.

Patients were given infliximab for three years after surgery, and those with no symptoms then ceased the medication. 83% of those then showed clinical symptoms after a few months, and they were put back onto a low dose of infliximab. This controlled the disease in all patients.

Whilst it's disappointing that most patients were unable to remain in remission without medication, the success of a lower than standard dosage is good news.